Clear-cell Metastatic Renal Cell Carcinoma

Also known as: Metastatic Clear Cell Renal Cancer / Metastatic Clear-cell Renal Cancer / Clear Cell Renal Cell Carcinoma Metastatic / Clear Cell Metastatic Renal Cell Carcinoma / Metastatic Clear Cell Renal Cell Carcinoma / Metastatic Clear-Cell Renal Cell Carcinoma / Metastatic Clear Cell Renal Carcinoma / Clear Cell, Metastatic Renal Cell Carcinoma / Metastatic Clear Cell Renal Cell Carcinoma (ccRCC) / Metastatic clear cell renal cell carcinoma (disorder) / Clear cell renal cell carcinoma (morphologic abnormality) / Hypernephroma / Renal cell carcinoma (morphologic abnormality) / Clear cell carcinoma of kidney (disorder) / Clear Cell Renal Cell Carcinoma / Renal clear cell carcinoma / Clear cell carcinoma of the kidney

Drug	Drug Name	Drug Description
DB08875	Cabozantinib	A tyrosine kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer.

Drug	Drug Name	Target	Type
DB08875	Cabozantinib	Cytochrome P450 3A4	enzyme
DB08875	Cabozantinib	Cytochrome P450 2C9	enzyme
DB08875	Cabozantinib	Hepatocyte growth factor receptor	target
DB08875	Cabozantinib	Vascular endothelial growth factor receptor 2	target
DB08875	Cabozantinib	Proto-oncogene tyrosine-protein kinase receptor Ret	target
DB08875	Cabozantinib	Cytochrome P450 2C8	enzyme

Drug	Drug Name	Phase	Status	Count
DB00041	Aldesleukin	1	Terminated	1
DB11595	Atezolizumab	1	Terminated	1
DB08875	Cabozantinib	1	Active Not Recruiting	1
DB05928	Dovitinib	1	Completed	1
DB01590	Everolimus	1	Completed	1
DB06186	Ipilimumab	1	Completed	1
DB06186	Ipilimumab	1	Recruiting	1
DB09035	Nivolumab	1	Active Not Recruiting	1
DB06132	Nivolumab	1	Completed	1
DB09035	Nivolumab	1	Completed	1
DB06589	Pazopanib	1	Completed	1
DB09037	Pembrolizumab	1	Terminated	1
DB01268	Sunitinib	1	Completed	1
DB01268	Sunitinib	1	Terminated	1
DB18314	Valemetostat	1	Recruiting	1
DB11930	Varlilumab	1	Terminated	2
DB06626	Axitinib	1 / 2	Recruiting	1
DB01590	Everolimus	1 / 2	Completed	1
DB01611	Hydroxychloroquine	1 / 2	Completed	1
DB13982	Lutetium Lu-177	1 / 2	Recruiting	1
DB09037	Pembrolizumab	1 / 2	Recruiting	1
DB08913	Radium Ra 223 dichloride	1 / 2	Unknown Status	1
DB09566	Radium Ra 223 dichloride	1 / 2	Unknown Status	1
DB12813	Radium Ra-223	1 / 2	Unknown Status	1
DB11142	Selenomethionine	1 / 2	Recruiting	1
DB00126	Ascorbic acid	2	Terminated	1
DB06626	Axitinib	2	Completed	1
DB06626	Axitinib	2	Not Yet Recruiting	1
DB06626	Axitinib	2	Recruiting	1
DB08875	Cabozantinib	2	Recruiting	3
DB01590	Everolimus	2	Completed	2
DB01590	Everolimus	2	Recruiting	1
DB01590	Everolimus	2	Terminated	1
DB05304	Girentuximab	2	Completed	1
DB06186	Ipilimumab	2	Completed	2
DB06186	Ipilimumab	2	Recruiting	1
DB09078	Lenvatinib	2	Recruiting	1
DB13982	Lutetium Lu-177	2	Completed	1
DB09035	Nivolumab	2	Active Not Recruiting	2
DB09035	Nivolumab	2	Completed	2
DB09035	Nivolumab	2	Recruiting	2
DB09035	Nivolumab	2	Terminated	1
DB06589	Pazopanib	2	Completed	1
DB06589	Pazopanib	2	Terminated	1
DB09037	Pembrolizumab	2	Recruiting	2
DB15766	Retifanlimab	2	Completed	1
DB11836	Sapanisertib	2	Completed	1
DB14935	Serabelisib	2	Completed	1
DB15036	Sitravatinib	2	Active Not Recruiting	1
DB01268	Sunitinib	2	Completed	2
DB01268	Sunitinib	2	Terminated	1
DB15043	Toripalimab	2	Not Yet Recruiting	1
DB11925	Vistusertib	2	Terminated	1
DB06589	Pazopanib	3	Terminated	1
DB01268	Sunitinib	3	Terminated	1
DB06589	Pazopanib	4	Completed	1
DB06589	Pazopanib	4	Terminated	1
DB01268	Sunitinib	4	Terminated	1
DB01268	Sunitinib	Not Available	Completed	2